Biopharma Leaders Unite To Stand With Science LEARN MORE Pfizer & BioNTech to Supply Singapore with Vaccine Candidate to Combat COVID-19 LEARN MORE U.S. CDC Committee of Independent Health Experts Recommends Vaccination with Pfizer and BioNTech COVID-19 Vaccine LEARN MORE Alibaba Cloud, Fintech Academy and Pfizer Partner to Accelerate Healthcare Innovations LEARN MORE LORBRENA® (lorlatinib) Significantly Improves Progression-Free Survival in First-Line ALK-Positive Lung Cancer LEARN MORE RECENT PRESS RELEASES 30/06/2020 - FDA Approves BAVENCIO as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial Carcinoma 30/06/2020 - European Commission Approves DAURISMO™ (glasdegib) for Certain Adult Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) 25/06/2020 - Pfizer Declares Third-Quarter 2020 Dividend 24/06/2020 - Pfizer and Wellcome Launch Surveillance Program to Combat Growing Threat of Antimicrobial Resistance in Sub-Saharan Africa 22/06/2020 - European Medicines Agency Validates Application for BAVENCIO® (avelumab) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma 22/06/2020 - Pfizer Announces Start of Four Phase 3 Clinical Trials for Investigational Vaccines 18/06/2020 - Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels and No Bleeding Events or Factor Usage in 3e13 vg/kg Cohort Following giroctocogene fitelparvovec (SB-525) Gene Therapy 18/06/2020 - Upjohn Announces Pricing of Senior Notes in Connection with the Proposed Combination of Mylan and Upjohn 16/06/2020 - Pfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with Analysts 12/06/2020 - Pfizer Invites Public to View and Listen to Webcast of June 18 Conference Call with Analysts to Review Data Presentations at Scientific Conferences during the Week of June 15th 11/06/2020 - FDA Approves Pfizer’s Oncology Supportive Care Biosimilar, NYVEPRIA™ (pegfilgrastim-apgf) 10/06/2020 - Pfizer Announces Positive Top-Line Results from JADE TEEN Trial of Abrocitinib in Adolescents with Moderate-to-Severe Atopic Dermatitis 03/06/2020 - Complete Results from Second Pivotal Monotherapy Study of Abrocitinib Published in JAMA Dermatology 02/06/2020 - Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference 02/06/2020 - Pfizer Establishes New Program to Support Continued Biotechnology Innovation Pagination First page « First Previous page ‹ Previous Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 Next page Next › Last page Last »
